Directory
>
Pradman Qasba
Pradman Qasba
Chief, Structural Glycobiology Section, CCR, NCI | National Cancer Institute (NCI)
Bethesda, Maryland, United States
Pradman Qasba
Summary
Pradman Qasba is a distinguished leader in the field of glycobiology, currently serving as the Chief of the Structural Glycobiology Section at the National Cancer Institute. With a career spanning over five decades, he has made significant contributions to the understanding of glycan structures and their roles in cancer biology. His academic journey began with a Ph.D. in Medicinal Chemistry from Munich University, equipping him with a robust scientific foundation. Pradman's extensive tenure at the National Cancer Institute reflects his commitment to advancing cancer research through innovative approaches. He is recognized for his expertise in structural biology and his ability to lead multidisciplinary teams. Outside of his professional achievements, Pradman is passionate about mentoring the next generation of scientists and fostering collaborative research initiatives. His long-standing career in a government institution highlights his dedication to public health and scientific advancement. Pradman continues to be an influential figure in his field, advocating for the importance of glycobiology in cancer treatment.
Pradman Qasba
Work Experience
Chief, Structural Glycobiology Section, CCR, NCI at
National Cancer Institute (NCI)
November 1972 - Present
Pradman Qasba
Education
Munich University, Munich, West Germany, Doctor Of Philosophy (Ph.D.)
January 1970 - January 1970
Frequently Asked Questions about Pradman Qasba
What is Pradman Qasba email address?
Pradman Qasba's primary email address is ******@cancer.gov. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Pradman Qasba work for?
Pradman Qasba is a Chief, Structural Glycobiology Section, CCR, NCI at National Cancer Institute (NCI), a company specializing in Scientific Research & Development Services.
Where Pradman Qasba graduated from?
Pradman Qasba holds a degree in Medecinal Chemistry from Munich University, Munich, West Germany.
How can I directly contact Pradman Qasba?
To contact Pradman Qasba directly, you can use the email address ******@cancer.gov. Complete contact information is available upon registration with Muraena.
Is Pradman Qasba an immigrant?
Yes, Pradman Qasba is an immigrant and currently based in United States
Who is Pradman Qasba?
Pradman Qasba is a distinguished leader in the field of glycobiology, currently serving as the Chief of the Structural Glycobiology Section at the National Cancer Institute. With a career spanning over five decades, he has made significant contributions to the understanding of glycan structures and their roles in cancer biology. His academic journey began with a Ph.D. in Medicinal Chemistry from Munich University, equipping him with a robust scientific foundation. Pradman's extensive tenure at the National Cancer Institute reflects his commitment to advancing cancer research through innovative approaches. He is recognized for his expertise in structural biology and his ability to lead multidisciplinary teams. Outside of his professional achievements, Pradman is passionate about mentoring the next generation of scientists and fostering collaborative research initiatives. His long-standing career in a government institution highlights his dedication to public health and scientific advancement. Pradman continues to be an influential figure in his field, advocating for the importance of glycobiology in cancer treatment.
Pradman`s contact details
******@cancer.gov
Colleagues
Branch Chief, Office of Workforce Planning and Development
Section Chief
Branch Chief, Management Support Branch, Office of Management Policy & Compliance
Chief, Data Ecosystems Branch at NCI CBIIT
Associate Branch Chief
Founder And Co-Chair Cancer And Aging Interest Group
Chief, Outcomes Research Branch
Branch Chief
Chief, Cancer Publications Branch
Lead, Global Cancer Research Training, Center for Global Health, US National Cancer Institute